Life (Jul 2021)

First-Trimester Maternal Folic Acid Supplementation Modifies the Effects of Risk Factors Exposures on Congenital Heart Disease in Offspring

  • Yanji Qu,
  • Shao Lin,
  • Michael S. Bloom,
  • Ximeng Wang,
  • Zhiqiang Nie,
  • Yanqiu Ou,
  • Jinzhuang Mai,
  • Xiangmin Gao,
  • Yong Wu,
  • Jimei Chen,
  • John Justino,
  • Hongzhuan Tan,
  • Jian Zhuang,
  • Xiaoqing Liu

DOI
https://doi.org/10.3390/life11080724
Journal volume & issue
Vol. 11, no. 8
p. 724

Abstract

Read online

This study aimed to examine effect modification of maternal risk factor exposures and congenital heart disease (CHD) by maternal folic acid supplementation (FAS)/non-FAS. We included 8379 CHD cases and 6918 CHD-free controls from 40 clinical centers in Guangdong Province, Southern China, 2004–2016. Controls were randomly chosen from malformation-free fetuses and infants and frequency matched to the echocardiogram-confirmed cases by enrollment hospital and year of birth. We used multiple regression models to evaluate interactions between FAS/non-FAS and risk factors on CHDs and major CHD categories, adjusted for confounding variables. We detected statistically significant additive and multiplicative interactions between maternal FAS/non-FAS and first-trimester fever, viral infection, and threatened abortion on CHDs. An additive interaction on CHDs was also identified between non-FAS and living in a newly renovated home. We observed a statistically significant dose-response relationship between non-FAS and a greater number of maternal risk factors on CHDs. Non-FAS and maternal risk factors interacted additively on multiple critical CHDs, conotruncal defects, and right ventricular outflow tract obstruction. Maternal risk factor exposures may have differential associations with CHD risk in offspring, according to FAS. These findings may inform the design of targeted interventions to prevent CHDs in highly susceptible population groups.

Keywords